The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
315.50
+5.50 (1.77%)
At close: May 24, 2026
Market Cap9.86B +7.7%
Revenue (ttm)13.48B +14.2%
Net Income788.34M +24.6%
EPS25.23 +24.6%
Shares Out 31.24M
PE Ratio12.50
Forward PEn/a
Dividend6.40 (2.03%)
Ex-Dividend DateOct 27, 2025
Volume19,319
Open311.00
Previous Close310.00
Day's Range310.30 - 316.90
52-Week Range273.80 - 371.00
Beta0.13
Analystsn/a
Price Targetn/a
Earnings DateSep 30, 2026

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Employees 5,200
Stock Exchange Dhaka Stock Exchange
Ticker Symbol IBNSINA
Full Company Profile

Financial Performance

In fiscal year 2025, DSE:IBNSINA's revenue was 11.88 billion, an increase of 4.51% compared to the previous year's 11.37 billion. Earnings were 633.19 million, a decrease of -5.57%.

Financial Statements